FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801260524> ?p ?o ?g. }

• W2801260524 abstract "Lacrimal adenoid cystic carcinoma (LACC) is one of the most common malignancies that affects lacrimal gland. MicroRNAs are known to play a crucial role as oncogenes or tumor suppressors. Specifically, miR-93 has been reported to play a crucial role in colorectal, breast, pancreatic, lung cancer and hepatocellular carcinoma. However, the role of miR-93 in LACC and the potential molecular mechanisms involved remain unknown. Therefore, we took the challenge to determine the involvement of miR-93 in the LACC by targeting BRMS1L.A total of 5 adenoid cystic carcinoma (ACC) of lacrimal gland patient tissues and their plasma were examined. Three normal lacrimal glands and three normal serums were collected as a control group. After surgical resection, the specimens were preserved in liquid nitrogen and stored at - 80 °C until RNA extraction. Afterwards, LACC cells with miR-93-5p overexpression were subjected to qRT-PCR and western blot for epithelial-mesenchymal transition (EMT) markers levels. Ability of LACC cell migration, invasion, proliferation and apoptosis was examined by wounded healing, transwell, CCK-8 and apoptosis assays. Afterwards, TargetScan was used to predict putative targets of miR-93-5p. Then, the examination was performed whether miR-93-5p targets BRMS1L by the use of luciferase reporter assays and western blotting. Finally, immunohistochemical staining was sone and all the images were taken using a microscope (Nikon, Tokyo).Our results showed that miR-93 was overexpressed in tissues and plasma of LACC patients compared to healthy controls. MiR-93 downregulated E-cadherin expression while increasing N-cadherin expression and significantly inhibited luciferase activity. Furthermore, western blotting results confirmed that miR-93-5p could inhibit BRMS1L expression. The BRMS1L staining in LACC tissues was weaker than in normal controls. In addition, miR-93-5p revealed a reverse correlation with the expression of BRMS1L. In addition, significant upregulation of E-cadherin and downregulation of N-cadherin were found when LACC cells were transfected with BRMS1L. Finally, miR-93-5p significantly enhanced TOP/FOP luciferase activity. Upregulation of BRMS1L reduced TOP/FOP luciferase activity while further overexpression of miR-93-5p could not rescue Wnt signaling activity.Our findings report that miR-93 promotes LACC cell migration, invasion, and proliferation via targeting downregulation of BRMS1L through regulation of Wnt signaling pathway." @default.
• W2801260524 created "2018-05-17" @default.
• W2801260524 creator A5012332793 @default.
• W2801260524 creator A5069849278 @default.
• W2801260524 creator A5070066511 @default.
• W2801260524 creator A5090674418 @default.
• W2801260524 date "2018-05-09" @default.
• W2801260524 modified "2023-10-16" @default.
• W2801260524 title "miR-93-5p enhance lacrimal gland adenoid cystic carcinoma cell tumorigenesis by targeting BRMS1L" @default.
• W2801260524 cites W1542899887 @default.
• W2801260524 cites W173809022 @default.
• W2801260524 cites W1967739793 @default.
• W2801260524 cites W1972121227 @default.
• W2801260524 cites W1975140356 @default.
• W2801260524 cites W1983502906 @default.
• W2801260524 cites W1998679638 @default.
• W2801260524 cites W2000571126 @default.
• W2801260524 cites W2005175510 @default.
• W2801260524 cites W2024073746 @default.
• W2801260524 cites W2047395460 @default.
• W2801260524 cites W2053702192 @default.
• W2801260524 cites W2054473942 @default.
• W2801260524 cites W2062575747 @default.
• W2801260524 cites W2066182837 @default.
• W2801260524 cites W2073079990 @default.
• W2801260524 cites W2091613784 @default.
• W2801260524 cites W2116799486 @default.
• W2801260524 cites W2120346211 @default.
• W2801260524 cites W2123287557 @default.
• W2801260524 cites W2130814352 @default.
• W2801260524 cites W2136367623 @default.
• W2801260524 cites W2147319300 @default.
• W2801260524 cites W2155278324 @default.
• W2801260524 cites W2168735334 @default.
• W2801260524 cites W2170860951 @default.
• W2801260524 cites W2198562037 @default.
• W2801260524 cites W2207212374 @default.
• W2801260524 cites W2222295279 @default.
• W2801260524 cites W2301716222 @default.
• W2801260524 cites W2420035042 @default.
• W2801260524 cites W2463742905 @default.
• W2801260524 cites W2554979574 @default.
• W2801260524 cites W2579367890 @default.
• W2801260524 cites W2612834634 @default.
• W2801260524 cites W2737344169 @default.
• W2801260524 cites W2745924582 @default.
• W2801260524 cites W2762418270 @default.
• W2801260524 cites W2765448441 @default.
• W2801260524 doi "https://doi.org/10.1186/s12935-018-0552-9" @default.
• W2801260524 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5944175" @default.
• W2801260524 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29760585" @default.
• W2801260524 hasPublicationYear "2018" @default.
• W2801260524 type Work @default.
• W2801260524 sameAs 2801260524 @default.
• W2801260524 citedByCount "20" @default.
• W2801260524 countsByYear W28012605242019 @default.
• W2801260524 countsByYear W28012605242020 @default.
• W2801260524 countsByYear W28012605242021 @default.
• W2801260524 countsByYear W28012605242022 @default.
• W2801260524 countsByYear W28012605242023 @default.
• W2801260524 crossrefType "journal-article" @default.
• W2801260524 hasAuthorship W2801260524A5012332793 @default.
• W2801260524 hasAuthorship W2801260524A5069849278 @default.
• W2801260524 hasAuthorship W2801260524A5070066511 @default.
• W2801260524 hasAuthorship W2801260524A5090674418 @default.
• W2801260524 hasBestOaLocation W28012605241 @default.
• W2801260524 hasConcept C104317684 @default.
• W2801260524 hasConcept C121608353 @default.
• W2801260524 hasConcept C126322002 @default.
• W2801260524 hasConcept C142724271 @default.
• W2801260524 hasConcept C145059251 @default.
• W2801260524 hasConcept C190283241 @default.
• W2801260524 hasConcept C204232928 @default.
• W2801260524 hasConcept C2776415932 @default.
• W2801260524 hasConcept C2777546739 @default.
• W2801260524 hasConcept C2779013556 @default.
• W2801260524 hasConcept C2779231225 @default.
• W2801260524 hasConcept C2779298748 @default.
• W2801260524 hasConcept C2781163425 @default.
• W2801260524 hasConcept C502942594 @default.
• W2801260524 hasConcept C55493867 @default.
• W2801260524 hasConcept C555283112 @default.
• W2801260524 hasConcept C71924100 @default.
• W2801260524 hasConcept C76419328 @default.
• W2801260524 hasConcept C85265743 @default.
• W2801260524 hasConcept C86803240 @default.
• W2801260524 hasConceptScore W2801260524C104317684 @default.
• W2801260524 hasConceptScore W2801260524C121608353 @default.
• W2801260524 hasConceptScore W2801260524C126322002 @default.
• W2801260524 hasConceptScore W2801260524C142724271 @default.
• W2801260524 hasConceptScore W2801260524C145059251 @default.
• W2801260524 hasConceptScore W2801260524C190283241 @default.
• W2801260524 hasConceptScore W2801260524C204232928 @default.
• W2801260524 hasConceptScore W2801260524C2776415932 @default.
• W2801260524 hasConceptScore W2801260524C2777546739 @default.
• W2801260524 hasConceptScore W2801260524C2779013556 @default.
• W2801260524 hasConceptScore W2801260524C2779231225 @default.
• W2801260524 hasConceptScore W2801260524C2779298748 @default.
• W2801260524 hasConceptScore W2801260524C2781163425 @default.
• W2801260524 hasConceptScore W2801260524C502942594 @default.

• next